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ABSTRACT
Background: Laparoscopic splenectomy (LS) has be-
come the standard approach for most splenectomy cases.
Bleeding is the main complication and cause for conver-
sion. We present our experience with the LigaSure and
discuss its advantage as a vessel sealing system in achiev-
ing safe vascular control.
Method: Over a 3-year period, we performed 12 consec-
utive LS using LigaSure at a single center. A literature
review of all the patients who had undergone laparo-
scopic splenectomy with of the LigaSure to achieve vas-
cular control at the hilum was carried out, assessing its
advantages and outcome.
Results: Twelve LS were performed. Eleven of these pa-
tients had ITP, and one patient had sickle cell disease. The
mean blood loss was 70mL (range, 50 to 460), and oper-
ating time was 126 minutes (range, 110 to 240). Two
postoperative complications occurred: portal vein throm-
bosis in one case and subphrenic collection in the other.
The literature review revealed 8 studies with 231 cases in
which the LigaSure was used to perform laparoscopic
splenectomy. A significant reduction in operating time
(average 102 minutes) and intraabdominal blood loss
(66mL) was observed with the LigaSure compared with
endostaplers.
Conclusion: The use of LigaSure and the semilateral
position results in a gain of time and safety in addition to
low intraoperative bleeding, need for transfusion, minimal
complications and a low conversion rate.
Key Words: Laparoscopic splenectomy, LigaSure, Bleed-
ing.
INTRODUCTION
Laparoscopic splenectomy (LS) was first performed in
1992 and has since gained popularity, particularly for
hematological disorders of the spleen in adult and pedi-
atric patients.1–4 LS is feasible, effective, and safe with low
morbidity rates and has become a rational alternative to
open splenectomy.4–6 The advantages of shorter postop-
erative hospital stay (3.6 versus 7.2 days) and lower com-
plication rates for the laparoscopic approach (15.5%) over
open splenectomy (26.6%) have been shown in a meta-
analysis.6 LS was associated with significantly fewer pul-
monary, wound, and infectious complications.6 The con-
cern however was longer operating time and increased
risk of intraoperative bleeding due to technical difficulties
in securing vascular control at the splenic hilum. With the
advent of vessel sealing systems like LigaSure (Valley Lab,
Boulder, CO), the dissection and vascular control of the
hilum became easier, leading to a decrease in operative
time and blood loss during LS.1–3 We evaluated 12 LS
performed using the LigaSure, without using any laparo-
scopic suture or endoscopic stapler and assessed the out-
come in terms of operating time, blood loss, and compli-
cations. The literature was reviewed to look at the
present evidence on the advantages and outcomes with
the LigaSure as a vessel-sealing system in LS.
MATERIALS AND METHODS
We reviewed all the patients who underwent laparoscopic
splenectomy from 2005 to 2008. During this period, we
performed 12 laparoscopic splenectomies using LigaSure
as the vessel-sealing device. Surgical indications were
idiopathic thrombocytopenic purpura in 11 patients and
sickle cell disease in 1 patient. There were 7 female and 5
male patients with an age range from 17 years to 56 years
(mean, 28). Body mass index ranged from 19 and 29
(mean, 24), and American Society of Anesthesiology
(ASA) scores was 1 (n8) or 11 (n4). The mean diam-
eter of the spleen was 12cm (range, 9.5 to 16). Preopera-
tive mean thrombocyte count were 28 000/mm
3 (range,
4000 to 125 000) in the patients with idiopathic thrombo-
cytopenic purpura, all of whom failed to respond to med-
ical treatment preoperatively. All patients were immu-
nized against pneumococcal infection at least one month
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SCIENTIFIC PAPERprior to splenectomy. Blood loss was measured by the
amount of blood accumulated in the suction reservoir
after excluding the amount of irrigation solution. Operat-
ing time was defined as the period between the beginning
of the incision and closure of the wounds.
Surgical Technique
Patients were operated on while in the right lateral decu-
bitus position with a flexed operating table. Pneumoperi-
toneum was performed with a Veress needle from the
umbilical position after nasogastric decompression. Pneu-
moperitoneum was maintained at 12mm Hg. The port
positions included a 10-mm port placed at the umbilicus
for 30
0 telescopes and a 5-mm trocar at the epigastrium.
Through this port, adhesions, if any, of the splenic flexure
of the colon were released to place the left lumbar trocar
(10mm), which was placed in the lumbar space between
the costal margin and the iliac crest. The epigastric port
was used for the retraction and elevation of the spleen
from caudal to cranial, and the lumbar port was used for
dissection, sealing, and cutting of the tissues and vessels.
At the beginning of the study, a fourth 5-mm trocar was
placed to the posterior axillary line of the left flank. Dis-
section of the spleen and sealing of the hilar vessels and
short gastric vessels were done with the 5-mm and 10-mm
LigaSure Atlas vessel-sealing system (Valley Lab, Boulder
CO, USA). No laparoscopic clips, sutures, or monopolar-
bipolar diathermy were used. After looking for accessory
splenic tissues, dissection and sealing of splenic vessels
was performed from the lower pole to the upper pole and
from lateral to medial. Techniques for opening the gastro-
splenic ligament to demonstrate the splenic tent or early
ligation of the splenic artery or dissection of the pancreatic
tail were not used. Hilar vessels were divided with a
10-mm LigaSure close to the splenic capsule, and short
gastric vessels, particularly at the upper pole close to the
stomach, were divided with a 5-mm LigaSure, which was
particularly useful in narrow spaces, such as that occur-
ring when dividing the gastrosplenic ligament near the
upper pole of the spleen. Because of splenic hanging in
the lateral decubitus position, gastric retraction medially
was unnecessary during short gastric vessel division. This
was followed by division of splenorenal and spleno-
phrenic ligaments to completely free the spleen of its
attachments. The spleen was then removed through the
lumbar trocar with an improvised plastic bag used for
delivering pathology specimen after enlarging the incision
to 15mm. The spleens were fragmented within the bag
with sponge holding forceps and removed through the
lumbar trocar site.
RESULTS
The mean weight of the spleen was 160g (range, 120 to
480). There was one ectopic spleen close to the hilum.
Mean operative blood loss was 70mL (range 50 to 460),
and the mean operative time was 126 minutes (range, 110
to 240). Operative time was reduced after a short learning
period. The nasogastric tube was removed on day 1, and
oral feeding was begun on day 2, postoperatively. No
mortalities and 2 morbidities occurred. One patient was
readmitted with a subphrenic collection that was aspirated
under ultrasound guidance. The other patient developed
portal vein thrombosis and presented with an acute ab-
domen 9 days after splenectomy. This patient was ex-
plored and was found to have a segment of infarcted
jejunum that was resected. Following postoperative anti-
coagulant therapy, the patient made an uneventful recov-
ery. No conversions were necessary. However, one pa-
tient required extension of the incision due to difficulty in
placing the spleen in the improvised plastic bag. Mean
hospital stay was 4 days (range, 3 to 6). The mean post-
operative platelet count was 1 800 000 (range 62 000 to
7 800 000). One of the patients with high postoperative
platelet count was carefully monitored with color Doppler
for any evidence of portal/splenic vein thrombosis and
was discharged on oral anticoagulants.
DISCUSSION
LS is considered the gold standard for the treatment of
benign hematological disorders of the spleen, particularly
for small-sized spleens in adults and pediatric patients.1–6
Like other laparoscopic procedures, LS offers numerous
advantages over open splenectomy, such as less postop-
erative pain and blood loss, faster recovery, shorter hos-
pital stay, and fewer complications.5,6 However, it is a
technically challenging procedure, and perioperative
bleeding is a major concern with LS. In the early era of LS,
individual hilar vessels were isolated and controlled using
clips or ligatures prior to division. The complex blood
supply of the spleen warranted a great number of clip
applications. These metal clips were potentially harmful
foreign bodies left behind. The use of a surgical stapler to
divide the splenic hilum quickens this surgical step. How-
ever, the Endo-GIA stapler requires proper positioning of
the device for hilar vascular control following accurate
dissection with meticulous skeletonization to exclude ex-
traneous tissues, positioning it as close to the spleen and
as far as possible from the tail of the pancreas. Prominent
splenic vessels, perihilar soft tissue, the close proximity of
the tail of the pancreas, and the narrow jaw opening of
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vascular stapler line, because of incomplete hilar transec-
tion.3,5 Pancreatic fistula or clinical pancreatitis are well-
documented complications after LS, as a consequence of
the tail of the pancreas being retained between the
jaws.2,5,7 The LigaSure vessel-sealing system was devel-
oped for both laparoscopic and open procedures as an
alternative to suture ligation, hemoclips, staplers, and ul-
trasonic coagulation for dealing with vessels and soft tis-
sue.1–3,5 LigaSure applies bipolar electrical energy to ves-
sel walls. Proteins like collagen and elastin within the
vessel walls are partially denatured, and the sealing pro-
duces a single compact structure that obliterates the lu-
men of the vessel. The hemostatic seal is characterized at
20 days by extensive fibrosis with minimal inflamma-
tion.8,9 The device can safely seal and divide vessels
7mm in diameter.1,7–9 The splenic veins however could
exceed 7mm in diameter at the hilum. In these situations,
by ligating the splenic artery initially over the superior
border of the pancreas, the splenic vein would collapse
and could be sealed securely with the LigaSure.1 Seals
have been shown to withstand a minimum of 3 times the
normal systolic pressure. LigaSure sealing causes low lat-
eral thermal spread (2mm), and the smoke produced is
also low.8,9 Because grasping, coagulating, and cutting are
done at the same time, frequent instrument interchange is
unnecessary and thus time is saved.1–3,10,11
A review of the literature pertaining to LS performed with
use of a vessel-sealing system including the present series
revealed 9 studies involving 243 patients.1–3,11–15 In these
studies, the procedure was completed by using vessel-
sealing systems as the only means of achieving hemostasis
without the use of clips and endostaplers. The common
indications included idiopathic thrombocytopenic pur-
pura, which was the most frequent indication (57%), fol-
lowed by hereditary spherocytosis (15%) and lymphoma
(11%) (Table 1). Other indications include thalassaemia,
parasitic or nonparasitic cysts, lymphangioma, thrombotic
thrombocytopenic purpura, and hemolytic anemia. The
average weight of the excised spleen was 243g (range, 80
to 1800), blood loss was 66mL (range, 0 to 875), and the
operating time was 102 minutes (range, 30 to 250). Com-
plications were seen in 7.4% (18 patients), the significant
among them being 2 cases each (0.82%) of portal vein
thrombosis and pancreatic fistula (Table 1). Other com-
plications include port-site bleeding, wound infection,
and general complications like deep vein thrombosis and
respiratory complications including pneumonia and pleu-
ral effusion. Nine patients required conversion for bleed-
ing from the hilum or splenic capsule, in most cases in the
initial learning phase.1–3,14
The concerns of operating time and the amount of blood
loss during LS have been addressed by Aydin et al1 in their
review comparing the use of LigaSure and endostaplers in
the transection of the splenic hilum. Comparing 1430
patients who had undergone LS with endostaplers and
clips with 144 patients in whom a vessel-sealing system
was used, the blood loss of 160mL to 382mL (average,
224) was much higher than 60mL to 80mL (average, 73)
when a vessel-sealing system was used.1
Although laparoscopic splenectomy has several advan-
tages over open splenectomy, longer operating time has
been its main disadvantage. Winslow and Brunt6 reviewed
2940 patients in 51 studies (2119 laparoscopic and 821
open splenectomies) and found that the operative times
were significantly longer in the laparoscopic splenectomy
group by over 60 minutes (114 vs 180). This prolonged
operative time did not improve with the use of staplers in
achieving vascular control of the hilum, as reported by
Bell and associates who found no significant improve-
ment in operative time over a 10-year period.16 The mean
operating time for large spleens where endostaplers and
clips were used for vascular control in laparoscopic sple-
nectomy was 156 minutes (range 95 to 170).1 However, a
significant improvement in mean operating time of 103
minutes (range, 71 to 125) was observed when a vessel-
sealing system was used to achieve vascular control.1 The
reported operative time was usually 2 hours, which was
comparable to the results of open splenectomy,1 and this
was substantiated by observations made in the literature
review (Table 1). This was partly achieved by the fact that
vessel-sealing systems perform dissection, coagulation,
and cutting with the same instrument, leading to less
instrument changing. Change of instrument may lead to
the risk of losing vision of the surgical area, which is of
outmost importance in the event of bleeding. Using a
multifunctional instrument like LigaSure enables rapid in-
tervention in such an event to stop bleeding and to de-
crease time consumption and blood loss.1–5 The comfort
and satisfaction rate of the surgeon is further enhanced,
because cutting of all the adhesions surrounding the
spleen, and coagulation of vessels of the splenic hilum
(splenic artery and vein) and gastrosplenic vessels can be
achieved with a single instrument.
The LigaSure vessel-sealing system thus offers some ad-
vantages compared with other instruments:
(1) it permits easy dissection of the spleen, reducing the
risk of damage to the pancreatic tail (the vascular pedicle
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JSLS (2010)14:547–552 551at the hilum can be sealed staying as far as possible from
the pancreas);
(2) it ensures minimal sticking, charring, and lateral ther-
mal spread (2mm);
(3) it prevents electric hazards;
(4) it reduces frequent instrument interchange, because
grasping, coagulability, and cutting are done at the same
time, saving time and avoiding accidental capsular tears,
which cause troublesome oozing;
(5) in overweight patients with fatty tissues, it is feasible to
seal lower polar vessels without perfect dissection or iso-
lation, which can cause unnecessary bleeding;
(6) it may be a cost-effective alternative for achieving
hemostasis;
(7) it is easy to use;
(8) no foreign material, such as clips, stapler, or sutures,
are left behind making it an attractive strategy in laparos-
copy surgery.1–5,11–15
CONCLUSION
We believe that a vessel-sealing system like LigaSure is
safe for vascular control in LS and can provide less blood
loss. This technique reduces operating time in LS and
removes the disadvantage of a longer operating period in
LS over the open splenectomy with acceptable complica-
tion and conversion rates. The ease and multifunction of
LigaSure in sealing vessels 7mm and cutting of tissue
without the need to change instruments enhances the
surgeon’s comfort and satisfaction level.
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